It has been documented that after addition of EGFR, MDM2 can bind to PPARγ and regulate the ubiquitination of PPARγ protein in colon cancer, and that MDM2 silencing can increase the level of PPARγ [12], which is further verified in bladder cancer. This evidence concerns the gene MDM2 and urinary bladder carcinoma.